ARCTURUS THERAPEUTICS HOLDINGS INC. Other Non-Current Liabilities
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Other Non-Current Liabilities of $497.00 thousand as of 2023-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2025-03-06
- 2023-12-31: Other Liabilities, Noncurrent $497.00K.
- 2023-09-30: Other Liabilities, Noncurrent $976.00K.
- 2023-06-30: Other Liabilities, Noncurrent $1.29M.
- 2023-03-31: Other Liabilities, Noncurrent $1.73M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2023-12-31 | $497.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $976.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.29M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $1.73M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.80M 10-K · filed 2024-03-14 |
| 2022-09-30 | $3.68M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $1.39M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $878.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $358.00K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |